Overall rank by patents
#5,175
Across all tracked assignees
USPTO PatentsView assignee record - 67 granted patents across 33 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
National holds 67 US patents across 33 technology areas, rank #5,175 of 50,000 tracked assignees.
National University Of Ireland, Galway has been granted 67 US utility patents between 2015 and 2025, placing National University Of Ireland, Galway at rank #5,175 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, National University Of Ireland, Galway is one of the more focused assignees in the PatentsView dataset. By volume, National sits between Minerva Surgical, Inc. (67 patents, rank #5,171) and Proterra Ag, Inc. (67 patents, rank #5,179) - the closest US assignees by grant volume. The composite Innovation Score of 51.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 44 grants, compared with 23 in the 2015–2019 window, a +91% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. National University Of Ireland, Galway's 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark National University Of Ireland, Galway against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MINERVA SURGICAL, INC.
67 patents
Magna Powertrain, Inc.
67 patents
Moen Incorporated
67 patents
NCS MULTISTAGE INC.
67 patents
ONCOTHERAPY SCIENCE, INC.
67 patents
OPTOS PLC
67 patents
Preh GmbH
67 patents
Proterra Ag, Inc.
67 patents
National University of Ireland, Galway
67 patents
What this shows National holds 67 patents at rank #5,175, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,175 in granted patent volume.
Other assignees with the most granted patents in National's primary technology class.
National's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 6.0% |
| 2016 | 4 | 6.0% |
| 2017 | 3 | 4.5% |
| 2018 | 7 | 10.4% |
| 2019 | 5 | 7.5% |
| 2020 | 14 | 20.9% |
| 2021 | 5 | 7.5% |
| 2022 | 9 | 13.4% |
| 2023 | 5 | 7.5% |
| 2024 | 8 | 11.9% |
| 2025 | 3 | 4.5% |
Top 15 of 33 technology areas
Overall rank by patents
#5,175
Across all tracked assignees
51.4 out of 100
How to use this portfolio
National's 67 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.